Bioline Rx reported $-2.34M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Arca Biopharma USD -34.43M 326K Dec/2025
Bio Path USD -488K 4.07M Sep/2025
Bioline Rx USD -2.34M 1.05M Mar/2026
Capricor Therapeutics USD -29.16M 2.87M Dec/2025